Hims & Hers Health Inc (HIMS) Stock Price, Quote & News

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 415 851 0195

Website: www.hims.com

Address:

2269 Chestnut Street, Suite 523, San Francisco, United States

PeterJPL Aug. 3 at 5:21 AM

🌅 4:00am ET Watchlist — August 3, 2026 $UPC – AH runner with no clear same-night confirmed company release. Momentum-first setup tied to its Best Praise acquisition and five China pharmaceutical patents. The all-stock $10.75M purchase expands the portfolio but creates dilution risk. $VIVK – AH runner with no fresh same-night catalyst. Traders are revisiting four recurring crude-oil transactions projected at roughly $289M, with broader annualized platform activity estimated near $1.5B. Watching volume, liquidity, debt conversions, and potential share issuance. $AXTI – Q2 revenue rose to $47.6M from $18.0M, gross margin reached 44.9%, and GAAP net income improved to $11.1M. Watching whether the AI data-center earnings breakout consolidates and continues. $HIMS – Volatile legal and earnings setup after regulators filed a lawsuit over health-data sharing and billing practices. Q2 earnings are scheduled after the close on August 10. $FCUV – Multi-day momentum

0 · Reply

Barron_Trump Aug. 3 at 4:19 AM

$BULL $RDW As Donald Trump’s son… this going back & forth about whether the war is going to end or not is getting annoying. $HIMS $SPY

1 · Reply

FromRockstoStocks Aug. 3 at 3:22 AM

$HIMS they their's thems Hims! Lets get it

0 · Reply

Mlanser Aug. 3 at 3:17 AM

$HIMS im in . This and $SMCI will be next multi baggers

0 · Reply

ANALYZING Aug. 3 at 2:40 AM

$HIMS still holding from 25.5. What a steal

0 · Reply

StokTrekR Aug. 3 at 12:12 AM

$ASTS $HIMS $ONDS

1 · Reply

MarketPulsee Aug. 3 at 12:03 AM

Mission: $500K Portfolio by 2030 Current Portfolio: $205K My 5-year price targets: $HIMS $27 → $120 $ASTS $59 → $446 $ONDS $8 → $30 $PNG.V $6 → $26 This portfolio is built around long-term themes: • AI infrastructure • Cloud & compute • Fintech • Digital health • Space communications Will every target be reached? Probably not. But if even a few of these companies execute as expected over the next five years, the upside could be meaningful. The goal isn't to predict every move. It's to own high-quality growth businesses and give them time to compound. Mission: $500K by 2030. Do you think it's achievable?

0 · Reply

DadSuggests Aug. 2 at 11:42 PM

$HIMS why are like the last 5 posts all AI bots saying “be careful”?

0 · Reply

WBM912 Aug. 2 at 10:28 PM

$HOOD WE ABOUT TO PUMP SO HARD TONIGHT AND THIS WEEK $HIMZ $HOOW $HIMS

0 · Reply

MarketAlpha5 Aug. 2 at 9:38 PM

$HIMS is one I’m watching carefully because the chart is starting to show some warning signs. The recent channel retest doesn’t look as strong as bulls would want. Price is showing signs of rejection, and the key level for me is the 200-week moving average. If that support fails, the downside risk increases and the stock could be forced into a deeper reset. I know it’s never popular to be bearish on a name people love, but the market doesn’t care about opinions — it follows price. Last time I pointed out weakness around the $37 area, many disagreed, and the stock eventually pulled back toward $15. Now I’m watching whether $HIMS can prove the bears wrong or if more downside is ahead. Nice to see you after the bell. What's your focus for tomorrow? Enjoy the evening.

0 · Reply

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

2026-07-30T13:58:09.000Z - 3 days ago

Hims & Hers Stock Jumps on Vow to ‘Vigorously’ Defend Against FTC’s ‘Baseless Claims’

META SNAP

Jul 30, 2026, 9:30 AM EDT - 3 days ago

FTC sues Hims & Hers for allegedly sharing patients' medical data with advertisers Meta and Snap

Jul 29, 2026, 6:05 PM EDT - 4 days ago

Hims & Hers sent users' health data to social media giants despite promising privacy, bombshell FTC lawsuit claims

Jul 29, 2026, 4:42 PM EDT - 4 days ago

Wednesday's Final Takeaways: Fed Holds Rates & HIMS Lawsuit

Jul 29, 2026, 2:24 PM EDT - 4 days ago

Hims and Hers shares fall 10% as FTC sues company over data, billing practices

Jul 29, 2026, 2:05 PM EDT - 4 days ago

FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big Tech

Jul 29, 2026, 1:51 PM EDT - 4 days ago

Hims & Hers Responds to FTC Lawsuit

2026-07-29T17:40:01.000Z - 4 days ago

Hims & Hers Health Stock Sinks on Privacy, Deceptive Billing Lawsuit

META SNAP

Jul 29, 2026, 12:34 PM EDT - 4 days ago

US FTC suing Hims & Hers for sending user health info to Meta, Snap

2026-07-24T16:34:28.000Z - 9 days ago

Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?

2026-07-24T16:05:53.000Z - 9 days ago

Hims & Hers falls -10.3%

2026-07-24T12:00:00.000Z - 9 days ago

Canaccord Expects Hims & Hers Stock (HIMS) to Outperform ‘Major Indices by Several Hundred Basis Points.’ Here’s Why

2026-07-23T20:09:29.000Z - 10 days ago

Here’s Why Hims & Hers Stock Soared 13% Today – July 23, 2026

Jul 23, 2026, 6:03 AM EDT - 11 days ago

Hims & Hers stands to gain if the FDA loosens restrictions on peptides

Jul 17, 2026, 4:17 PM EDT - 16 days ago

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

Jul 13, 2026, 4:05 PM EDT - 20 days ago

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Jul 2, 2026, 12:24 PM EDT - 4 weeks ago

Amplify Online Retail ETF Rides a Summer Surge in Performance

CART IBUY TRIP W

Jul 1, 2026, 2:15 PM EDT - 4 weeks ago

Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review

Jun 25, 2026, 6:04 AM EDT - 5 weeks ago

Hims' obesity drug business may get boost as employers drop coverage

Jun 18, 2026, 2:14 PM EDT - 6 weeks ago

Living Longer Is Big Business. These Stocks Will Benefit.

ABT DXCM GH PLNT

Jun 11, 2026, 2:00 PM EDT - 7 weeks ago

Hims & Hers Health Transcript: AGM 2026

Jun 4, 2026, 9:00 AM EDT - 2 months ago